APOE Genotype, Memory Test Performance, and the Risk of Alzheimer’s Disease in the Canadian Study of Health and Aging

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Dementia and Geriatric Cognitive Disorders

• Publication date

  2002-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1159/000066670PMID 12457072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic testing for late-onset Alzheimer's disease. AGS Ethics Committee.

  2001cited by this paper
• Study Sampling in the Canadian Study of Health and Aging

  2001cited by this paper
• Memory decline in healthy older people

  2001cited by this paper
• The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

  2000cited by this paper
• The incidence of dementia in Canada

  2000cited by this paper
• The effect of apolipoprotein E genotypes in Alzheimer's disease: Data from the Canadian study of health and aging

  2000cited by this paper
• The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample.

  2000cited by this paper
• Mild cognitive impairment: conceptual basis and current nosological status

  2000cited by this paper
• Apolipoprotein E genotypes and cognitive functions in healthy elderly persons

  1999cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Ethical Guidelines of the Alzheimer Society of Canada

  1998cited by this paper
• Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects

  1998cited by this paper
• Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

  1997cited by this paper
• Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

  1997cited by this paper
• Prediction of probable Alzheimer's disease in memory-impaired patients

  1996cited by this paper
• Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging.

  1996cited by this paper
• A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment

  1996cited by this paper
• Apolipoprotein E and Alzheimer disease.

  1995cited by this paper
• Neuropsychological detection of dementia: an overview of the neuropsychological component of the Canadian Study of Health and Aging.

  1995cited by this paper
• Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults

  1995cited by this paper
• Canadian study of health and aging: study methods and prevalence of dementia.

  1994cited by this paper
• Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele.

  1994cited by this paper
• Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E ε4 Allele

  1994cited by this paper
• [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].

  1993cited by this paper
• Canadian study of health and aging

  1992cited by this paper
• Memory function in normal aging

  1992cited by this paper
• Cued recall and early identification of dementia.

  1991cited by this paper
• Cued recall and memory disorders in dementia.

  1989cited by this paper
• The Modified Mini-Mental State (3MS) examination.

  1987cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• CME Practice parameter:

  year unknowncited by this paper

• Efficacy and Concurrent Validity of Computerized Brain Training Based on Everyday Living (BTEL) Based on Instrumental Activities of Living for Cognitively Healthy Old Individuals: A Preliminary Study

  2024cites this paper
• Mapping the long-term delayed recall-based cortex-hippocampus network constrained by the structural and functional connectome: a case-control multimodal MRI study

  2023cites this paper
• Depressive symptoms and related factors among workers in care institutions for older persons in Japan: a cross-sectional study

  2019cites this paper
• Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility

  2017cites this paper
• The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview

  2016cites this paper
• The role of neuropsychology in prodromal dementia

  2011cites this paper
• The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis.

  2011cites this paper
• Consumo de frutas e hortaliças e funcionamento cognitivo em idosos

  2010cites this paper
• The effects of causative and susceptibility genes on the development of Alzheimer's disease: A meta-analytic approach

  2008cites this paper
• Distribution of APOE Genotypes in a Memory Clinic Cohort

  2008cites this paper
• APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.

  2008cites this paper
• APOE ε4 allele is associated with cognitive impairment in patients with multiple sclerosis

  2008cites this paper
• Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve.

  2007cites this paper
• Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease

  2006cites this paper
• Differenzialdiagnostik von Gedächtnisstörungen - Theorie und Praxis

  2005cites this paper
• APOE Genotype, Vascular Risk Factors, Memory Test Performance and the Five-Year Risk of Vascular Cognitive Impairment or Alzheimer’s Disease

  2005cites this paper
• A clinical perspective of mild cognitive impairment: what radiologists should know.

  2005cites this paper
• Apolipoprotein E and cognitive performance: a meta-analysis.

  2004cites this paper
• Black and White Differences in Cognitive Function Test Scores: What Explains the Difference?

  2004cites this paper
• Geriatric Psychiatry

  2003cites this paper